Bruker lowers 2025 EPS outlook after Q3 revenue dips 0.5% and GAAP loss widens
Bruker reported third-quarter 2025 revenue of $860.5 million, down 0.5% from a year earlier, and a GAAP diluted loss of $(0.41) per share, which included $119.4 million of goodwill and intangible impairment charges and $34.5 million of restructuring charges. Non-GAAP diluted EPS was $0.45, compared with $0.60 a year earlier. The company lowered its FY2025 non-GAAP EPS outlook to $1.85 to $1.90, citing earlier market weakness and EPS dilution from a higher share count.
Key points
- Q3 2025 revenue $860.5 million, down 0.5% year-over-year and down 4.5% organically
- Q3 2025 GAAP diluted loss $(0.41) per share versus EPS of $0.27 a year earlier; non-GAAP diluted EPS $0.45 versus $0.60
- FY2025 guidance: revenue $3.41 to $3.44 billion and non-GAAP EPS $1.85 to $1.90
- FY2026 cost-savings initiatives of $100 to $120 million are progressing toward the high end of the target
The filing
Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.